Evidence map›Paper›PMID 37949857›Full record

ArticleNature communications2023

A closed translocation channel in the substrate-free AAA+ ClpXP protease diminishes rogue degradation.

Alireza Ghanbarpour, Steven E Cohen, Xue Fei, Laurel F Kinman, Tristan A Bell, Jia Jia Zhang, Tania A Baker, Joseph H Davis, Robert T Sauer

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular mechanisms of mitochondrial AAA+ proteases.The Journal of biological chemistry · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Automated model-free analysis of cryo-EM volume ensembles with SIREn.bioRxiv : the preprint server for biology · 2024
    Article
  18. Review
  19. A proteolytic AAA+ machine poised to unfold a protein substrate.bioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alireza GhanbarpourDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.ORCID 0000-0002-7485-029X
Steven E CohenDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.ORCID 0000-0002-3193-0740
Xue FeiDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.
Laurel F KinmanDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.ORCID 0000-0001-6822-9352
Tristan A BellDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.
Jia Jia ZhangDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.ORCID 0000-0002-3003-4485
Tania A BakerDepartment of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA.ORCID 0000-0002-0737-3411
Joseph H Davis *Department of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA. jhdavis@mit.edu.ORCID 0000-0002-8858-8907
Robert T Sauer *Department of Biology Massachusetts Institute of Technology Cambridge, Cambridge, MA, 02139, USA. bobsauer@mit.edu.ORCID 0000-0002-1719-5399
Massachusetts Institute of Technology · USIIT@MIT · US

Funding

PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCEST32GM007287 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELL, STEPHEN P., KEATING, AMY E · 1985 to 2019
$40.8M
Tools to determine and analyze the structures of molecular machines in motionR01GM144542 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Joseph Davis · 2022 to 2026
$1.6M
Structure and function of ClpXPR35GM141517 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SAUER, ROBERT T · 2021 to 2024
$1.5M
NIGMS NIH HHS R01 GM144542NIGMS NIH HHS R35 GM141517NIGMS NIH HHS T32 GM007287
6 · The paper itself

Abstract

AAA+ proteases degrade intracellular proteins in a highly specific manner. E. coli ClpXP, for example, relies on a C-terminal ssrA tag or other terminal degron sequences to recognize proteins, which are then unfolded by ClpX and subsequently translocated through its axial channel and into the degradation chamber of ClpP for proteolysis. Prior cryo-EM structures reveal that the ssrA tag initially binds to a ClpX conformation in which the axial channel is closed by a pore-2 loop. Here, we show that substrate-free ClpXP has a nearly identical closed-channel conformation. We destabilize this closed-channel conformation by deleting residues from the ClpX pore-2 loop. Strikingly, open-channel ClpXP variants degrade non-native proteins lacking degrons faster than the parental enzymes in vitro but degraded GFP-ssrA more slowly. When expressed in E. coli, these open channel variants behave similarly to the wild-type enzyme in assays of filamentation and phage-Mu plating but resulted in reduced growth phenotypes at elevated temperatures or when cells were exposed to sub-lethal antibiotic concentrations. Thus, channel closure is an important determinant of ClpXP degradation specificity.

Indexed as

Escherichia coliEscherichia coli ProteinsAdenosine TriphosphatasesATPases Associated with Diverse Cellular ActivitiesEndopeptidase ClpHumansProteolysisTranslocation, GeneticAdenosine TriphosphatasesATPases Associated with Diverse Cellular ActivitiesEndopeptidase ClpEscherichia coli Proteins

Identifiers

PMID37949857
PMCPMC10638403
OpenAlexW4388567760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.